You are here

Research Projects

Antiepileptic drug is the mainstay of treatment modality for epilepsy. People with epilepsy often require lifelong antiepileptic drug treatment....

The COVID19 pandemic has re-emphasised the need for a good understanding of immune memory and its longevity. Our technology to detect antigen-...

Commonly used measures of disability in patients with MS poorly reflect disease severity and change over time, and are particularly insensitive to...

Lung cancer is the leading cause of cancer-related death in both men and women in the United States, accounting for nearly one-quarter of all cancer...

The iBrain Lab, headed by internationally acclaimed researcher Professor Meng Law, is currently working on two algorithms to improve patient care and...
Supervisor: Dr Ben Sinclair

Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is...

The Department of Diabetes at the Central Clinical School (CCS) is a part of Monash University’s Faculty of Medicine, Nursing and Health Sciences (...

Bariatric surgery is one of the most powerful health interventions available. A range of established surgical options are available, however,...
Supervisor: Dr Paul Burton

Multiple sclerosis, an autoimmune, neurodegenerative condition, is the most common cause of non-traumatic neurological disability in young adults,...
Supervisor: Dr Vilija Jokubaitis

Klebsiella pneumoniae is a ubiquitous bacterium that can inhabit a broad variety of host and environmental niches; from the human gut, to companion...
Supervisor: Dr Kelly Wyres

BACKGROUND The threat of antimicrobial resistant pathogens is a growing and present danger in modern life. The Klebsiella pneumoniae species complex...
Supervisor: Dr Kelly Wyres

The global importance of addressing cardiovascular disease and hypertension cannot be overestimated; this field needs new insights and novel...
Supervisor: Dr Morag Young

Genetic resistance to treatment has been well described in cancer, however, non- genetic or epigenetic resistance mechanisms are less clear and are...
Supervisor: Dr Omer Gilan

Although multiple sclerosis (MS) is considered to be a disease of the central nervous system, there is a vast array of recent data implicating the...
Supervisor: Dr Mastura Monif

Damage to myelin, the insulating sheath surrounding nerves, is a common consequence of traumatic brain injury. Emerging evidence suggests that white...
Supervisor: Dr Bridgette Semple

Chronic breathlessness is extremely common in patients with chronic, non-malignant lung and heart conditions. It is extremely unpleasant and...

How do brain waves control cognitive processes? Using a combination of in vivo electrophysiology and sophisticated cognitive paradigms of working...

Recent genetics work has identified a new cause of neurodegeneration in people who were previously identified as having an ‘idiopathic’ (i.e. unknown...
Supervisor: Dr Ian Harding

Parkinsonian diseases, Huntington’s disease, and Spinocerebellar ataxias are progressive and fatal neurological disorders characterised by atrophy in...
Supervisor: Dr Ian Harding

Current therapies for epilepsy are symptomatic, only suppressing the symptoms (seizures), but do not impact the development or progression of disease...

Pages